Of the respondents, 69% would frequently PSA test a man attending with lower urinary tract symptoms, 80% would frequently PSA test a man with a family history of prostate cancer, 11% would frequently test men with a family history of breast cancer and 32% would PSA test a man as part of an occupational health assessment. Here, KLK3 is linked to breast carcinoma.